Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-06 Sale |
2023-03-08 4:25 pm |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
831 | $15.26 | $12,684 | 63,429 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 7:04 pm |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
2,368 | $15.96 | $37,796 | 43,260 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-07 8:49 pm |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
1,023 | $16.85 | $17,234 | 79,311 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 4:15 pm |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
935 | $17.75 | $16,599 | 31,734 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 4:47 pm |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
933 | $34.2 | $31,908 | 22,167 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-02 Option Award |
2023-03-06 6:57 pm |
N/A 2033-03-02 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
76,800 | $0 | 120,060 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:49 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
48,600 | $0 | 79,311 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 3:53 pm |
N/A 2031-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
38,300 | $0 | 60,467 (Direct) |
View |
| 2020-05-31 Ownership |
2021-02-16 6:32 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
1,004 | $14.45 | 23,100 (Direct) |
View |
| 2020-11-30 Ownership |
2021-02-16 6:32 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
233 | $23.05 | 23,100 (Direct) |
View |
| 2020-10-26 Exercise |
2020-10-27 2:03 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
2,668 | $6.52 | 168,943 (Direct) |
View |
| 2020-10-26 Exercise |
2020-10-27 2:03 pm |
N/A 2029-10-28 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
2,668 | $0 | 168,943 (Direct) |
View |
| 2020-10-22 Exercise |
2020-10-23 1:27 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
2,695 | $6.52 | 168,943 (Direct) |
View |
| 2020-10-22 Exercise |
2020-10-23 1:27 pm |
N/A 2029-10-28 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
2,695 | $0 | 168,943 (Direct) |
View |
| 2020-10-15 Exercise |
2020-10-16 2:06 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
7,500 | $6.52 | 168,943 (Direct) |
View |
| 2020-10-15 Exercise |
2020-10-16 2:06 pm |
N/A 2029-10-28 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
7,500 | $0 | 168,943 (Direct) |
View |